# Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

> **NCT07183020** · — · ENROLLING_BY_INVITATION · sponsor: **Skripuletz, Thomas Prof. Dr.** · enrollment: 1142 (estimated)

## Conditions studied

- Multiple Sclerosis
- Clinically Isolated Syndrome (CIS)

## Interventions

- **DIAGNOSTIC_TEST:** Oligoclonal bands and kappa free light chains (KFLC)

## Key facts

- **NCT ID:** NCT07183020
- **Lead sponsor:** Skripuletz, Thomas Prof. Dr.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-10-27
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 1142 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07183020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07183020, "Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07183020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*